These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38686195)

  • 21. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
    Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
    Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-20b-5p is a novel biomarker for detecting prostate cancer.
    Zhai TY; Dou M; Ma YB; Wang H; Liu F; Zhang LD; Chong T; Wang ZM; Xue L
    Oncol Lett; 2022 Dec; 24(6):426. PubMed ID: 36311688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of ferritin with prostate cancer.
    Su Q; Lei T; Zhang M
    J BUON; 2017; 22(3):766-770. PubMed ID: 28730787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary endogenous peptides as biomarkers for prostate cancer.
    De Souza Dutra C; Da Cruz Schafhauser D; Hentz M; Mayer NR; Pinheiro RM; Baierle G; Kist DR; Bullé DJ; Donaduzzi RC; Bohmgahren MF; Zaha A; Ferreira HB; Possuelo LG; Monteiro KM
    Oncol Lett; 2023 Apr; 25(4):173. PubMed ID: 36970608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA.
    Bourefis A; Berredjem H; Djeffal O; Le TK; Giusiano S; Rocchi P
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy.
    Sun C; Song C; Ma Z; Xu K; Zhang Y; Jin H; Tong S; Ding W; Xia G; Ding Q
    Proteome Sci; 2011 Apr; 9():22. PubMed ID: 21504578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
    Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
    J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.
    Pérez-Rambla C; Puchades-Carrasco L; García-Flores M; Rubio-Briones J; López-Guerrero JA; Pineda-Lucena A
    Metabolomics; 2017; 13(5):52. PubMed ID: 28804274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
    Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
    Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
    Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
    Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population.
    Shen M; Chen W; Yu K; Chen Z; Zhou W; Lin X; Weng Z; Li C; Wu X; Tao Z
    Exp Mol Pathol; 2011 Feb; 90(1):97-100. PubMed ID: 20970419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Diagnostic Value of Serum TGF-β1, p2PSA Combined with PSA in Prostate Cancer.
    Guo X; Sun X; Ye P
    Altern Ther Health Med; 2024 Jul; 30(7):184-191. PubMed ID: 37971439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.
    Su Z; Wang G; Li L
    Cancer Biomark; 2023; 38(2):143-159. PubMed ID: 37781794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer.
    Chunhua L; Zhao H; Zhao H; Lu Y; Wu J; Gao Z; Li G; Zhang Y; Wang K
    Transl Oncol; 2018 Jun; 11(3):628-632. PubMed ID: 29574327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.